First Conference “Advancements in Animal-Free Research and Translational Medicine” in Munich
Numerous innovative applications will be highlighted throughout the day. We will discuss the translational applicability and challenges associated with mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) in the therapeutic context. Moreover, we will look at the utilization of human adipocyte spheroids as an innovative model for obesity research to provide insights into the in vitro capabilities for physiologically relevant conditions. Lastly, the scalability of cardiac organoids for preclinical applications will be demonstrated, establishing their importance for cardiovascular research and pharmacological advances. Alongside fantastic talks, the conference will be a fruitful environment for discussions and the fostering of new collaboration.
Discussions will extend from classic 2D cell culture work onto humanized multi-organoid systems for disease modeling and pharmacodynamics, illustrating their potential for simulating multi-layered disease states and therapeutic interventions.
Let´s exchange ideas and solutions, and find out more about applications, including the efficacy, reproducibility, and potential impact of serum substitutes on experimental outcomes. Through the multiple interdisciplinary discussions and presentations, this conference presents the perfect opportunity to get together and network with other scientists and experts in the field.
Upon request, we will be more than happy to provide certificates of registration and attendance.
Location: GREFIS Hotel GmbH, Lohenstraße 5, 82166 Gräfelfing, Germany
Registration: Early Bird and PELOClub Members: 349 Euros (register by April 30, 2024) | Standard fee: 399 Euros
Upon request, certificates of registration and attendance will be provided.
Registration: Email conference@pelobiotech.com; https://www.pelobiotech.com/resources/conferences.html